China Pacific Insurance (Group) Co., Ltd. (02601) Releases Q3 2025 Solvency Report for Subsidiary China Pacific Life Insurance Co., Ltd.

Bulletin Express
2025/10/30

China Pacific Insurance (Group) Co., Ltd. (02601) published an overseas regulatory announcement, attaching the Q3 2025 Solvency Report Summary from its subsidiary China Pacific Life Insurance Co., Ltd. The report discloses key financial and risk management information for the quarter ended September 30, 2025.

China Pacific Life Insurance Co., Ltd. reported admitted assets of approximately RMB2.6173 trillion and admitted liabilities of around RMB2.2550 trillion at the end of the reporting period. Actual capital stood at about RMB362.27 billion, while minimum capital reached around RMB183.98 billion. These figures translate into a core solvency margin ratio of 124% (down from 136% in the previous quarter) and a comprehensive solvency margin ratio of 197% (down from 215%). The company attributes these changes primarily to fluctuations in the capital market and adjustments in insurance contract liabilities under solvency reporting.

During the third quarter, gross written premiums were equivalent to roughly RMB64.43 billion. From the start of 2025 to the end of Q3, gross written premiums totaled about RMB232.44 billion, with net profit of approximately RMB34.08 billion and total assets of around RMB2.6774 trillion. The company’s net assets were close to RMB152.54 billion, while insurance contract liabilities amounted to roughly RMB2.3074 trillion.

Regarding regulatory updates, the National Financial Regulatory Administration (NFRA) issued a warning and a fine of RMB3.53 million against China Pacific Life Insurance Co., Ltd.’s head office in July 2025 concerning issues related to insurance terms, pricing, and data reporting. Certain local branches also received administrative penalties and regulatory opinion letters for compliance-related reasons. The company’s most recent assessments from the regulator maintained an AA rating for the first two quarters of 2025 under the Insurance Regulatory Rating (IRR) regime.

The Q3 2025 Solvency Report Summary indicates that China Pacific Life Insurance Co., Ltd. continues to strengthen its risk management practices in areas such as operational and reputational risk. Liquidity coverage ratios remain at generally sufficient levels under both normal and stress scenarios. The company states it will persist in refining strategies for regulatory compliance, reinforcing corporate governance, and focusing on long-term, stable development of its life insurance business.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10